Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 14/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | RAPGEF3 | O95398 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 1.00 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.80 |
| ▸ | PDE4A | P27815 | 1/20 | 0.78 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.78 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.78 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.78 |
| ▸ | MEN1 | O00255 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclic Adenosine Monophosphate SCHEMBL18716064 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL15893189 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL18934079 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| SCHEMBL22434642 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829653 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829820 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829591 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829670 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL23829673 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN | |
| Cyclic Adenosine Monophosphate SCHEMBL20912149 | 1.00 | STING1 (1.00) | STING1LMNARAPGEF3KMT2AGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 156915 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146256-A1 | YEAST STRAINS EXHIBITING PROLONGED PERSISTENCE DURING A PLURALITY OF FERMENTATION CYCLES | DANSTAR FERMENT AG (CH) | 2026-05-28 | — | — | US | claimed |
| EP-4746704-A2 | METHODS FOR CRYOPRESERVING CELLS FOR MODELING A HUMAN BRAIN OR A HUMAN BLOOD-BRAIN BARRIER | Icahn School of Medicine at Mount Sinai (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747250-A1 | KINASE INHIBITORS | The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4746864-A1 | C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION | Keto Innovations, LLC (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122094676-A | Organic compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-122094677-A | Organic compound | — | 2026-05-26 | — | — | CN | claimed |
| CN-114974464-B | Method and apparatus for predicting antagonists, medium and device | LANZHOU UNIVERSITY (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-122074090-A | Diversified phage synthesis and engineering platform | 修兰教育基金管理公司 | 2026-05-22 | — | — | CN | claimed |
| EP-3530728-B1 | METHOD FOR PRODUCING PERIPHERAL NERVE CELLS | UNIV GUNMA NAT UNIV CORP (JP) | 2026-05-20 | — | — | EP | claimed |
| US-12630801-B2 | Stem cell-derived Schwann cells | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-19 | — | — | US | claimed |
| US-4460765-A | Enzyme inhibitor produced by cultivation of streptomyces microorganisms | SANKYO COMPANY LIMITED (JP) | 1984-07-17 | — | — | US | claimed |
| US-4444778-A | ANTISEROTONINE AGENTS | COUGHLIN SHAUN R | 1984-04-24 | — | — | US | claimed |
| US-4433061-A | ADDING A SOURCE OF DIVALENT CATION TO MINIMIZE INTERFERENCE OF CALCIUM CATIONS | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1984-02-21 | — | — | US | claimed |
| US-4426446-A | Leucocyte adherence inhibition assay for detection of cancer | HOFFMANN-LA ROCHE INC. (US) | 1984-01-17 | — | — | US | claimed |
| US-4390274-A | Use of a method, particularly an automatic method, for measuring light as well as improvements and apparatuses for carrying out the same | MINNESOTA MINING AND MANUFACTURING COMPANY, A CORP OF DE. | 1983-06-28 | — | — | US | claimed |
| EP-0071357-A1 | Pharmaceutical and dietary composition when used for enhancement of 1-series PG production | EFAMOL LIMITED (GB) | 1983-02-09 | — | — | EP | claimed |
| EP-0044527-A1 | Substituted derivatives of benzyl triesters of cyclic adenosin-3',5'-phosphate, method for their preparation and pharmaceutical compositions containing them | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1982-01-27 | — | — | EP | claimed |
| EP-0011828-A1 | Pharmaceutical combinations including hydantoin derivatives, pharmaceutical formulations containing the combinations and methods of making the formulations | THE WELLCOME FOUNDATION LIMITED (GB) | 1980-06-11 | — | — | EP | claimed |
| US-4115538-A | RADIOIMMUNOASSAY; ADENOSINE-3',5'-CYCLIC MONOPHOSPHATE, GUANOSINE-3',5'-CYCLIC MONOPHOSPHATE | YAMASU SHOYU KABUSHIKI KAISHA (JP) | 1978-09-19 | — | — | US | claimed |
| US-4010148-A | Purified thymosin and process | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 1977-03-01 | — | — | US | claimed |